Michael DePeau-Wilson

Michael DePeau-Wilson is a journalist who covers psychiatry, long covid, and infectious diseases among other clinical news. He has also reported on pain medicine, anesthesiology, interventional cardiology and astronomy. Michael graduated from the Craig Newmark Graduate School of Journalism at CUNY with a focus on health and science reporting. He received his bachelor's degree from Valdosta State University. With over nine months of experience at MedPage Today as part of their enterprise and investigative team, he joined in May 2022. His primary topics include psychiatry, long covid, and infectious diseases.

95%

The Daily's Verdict

This author is known for its high journalistic standards. The author strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. The author has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.

Bias

100%

Examples:

No current examples available.

Conflicts of Interest

100%

Examples:

No current examples available.

Contradictions

95%

Examples:

  • In a 24-month study, estimated weight gain for bupropion was lower than sertraline (Zoloft) at all time points: 6 months (-0.80 kg), 12 months (-0.71 kg), and 24 months (-0.91 kg).
  • Patients who took Lexapro or Paxil gained about a pound more on average than those who took Zoloft in the first six months.
  • Study of 183,118 patients linked bupropion (Wellbutrin) to the least amount of weight gain compared to other first-line antidepressants.
  • Those on those medications were 10 to 15 percent more likely to gain at least five percent of their starting weight compared to users of five other commonly-prescribed antidepressants, like sertraline.
  • Users of escitalopram (Lexapro) and paroxetine (Seroxat) gained roughly 1 pound more than those on sertraline after six months.

Deceptions

85%

Examples:

  • Bupropion led to the least amount of weight gain across all time points compared to the other medications...
  • Multiple first-line antidepressant medications were broadly linked with weight gain...

Recent Articles

New Study Reveals Which Antidepressants Are Most Likely to Cause Weight Gain

New Study Reveals Which Antidepressants Are Most Likely to Cause Weight Gain

Broke On: Monday, 01 July 2024 A recent study published in the Annals of Internal Medicine found that escitalopram and paroxetine users gained roughly 1 pound more than sertraline users after six months, with a higher likelihood of gaining at least 5% of their baseline weight. Bupropion saw the least amount of weight gain among first-line antidepressants. The study offers more detailed information on antidepressant impact on weight gain and aims to help providers and patients make informed decisions.